Estrogen and CCK1 receptor modification of μ-opioid receptor binding in the cortex of female rats

Brain Research

Volumn 1073-1074, Issue 1, 2006, Pages 316-320

  Quesada, Arnulfo ^a   Micevych, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Opioid; Cholecystokinin; Cortex; Estrogen; Protein protein interaction; Receptor binding

Indexed keywords

CCK 8S; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ESTROGEN; JMV 179; LORGLUMIDE; MU OPIATE RECEPTOR; N TERT BUTYLOXYCARBONYLCHOLECYSTOKININ[27-32][28,31 NORLEUCINE] PHENETHYL ESTER; TETRAGASTRIN; UNCLASSIFIED DRUG; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DRUG DERIVATIVE; HORMONE ANTAGONIST; NARCOTIC ANALGESIC AGENT; PROGLUMIDE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; CHO CELL; COMPARATIVE STUDY; CRICETULUS; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; HAMSTER; LONG EVANS RAT; METABOLISM; METHODOLOGY; PHYSIOLOGY; PROTEIN BINDING; RADIOASSAY;

ANIMALIA;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; CRICETULUS; DRUG INTERACTIONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ESTROGENS; FEMALE; HORMONE ANTAGONISTS; OVARIECTOMY; PROGLUMIDE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, LONG-EVANS; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, OPIOID, MU; SINCALIDE; TRITIUM;

EID: 33644954478     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.12.023     Document Type: Article

References (44)

1. L.F. Agnati New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram Med. Biol. 60 4 1982 183 190
2. L.F. Agnati A brief appraisal on some aspects of the receptor-receptor interaction Neurochem. Int. 27 2 1995 139 146
3. M. Carlberg Autoradiographic localization of cholecystokinin A and B receptors in rat brain using [125I]d-Tyr25 (Nle28,31)-CCK 25-33S Eur. J. Neurosci. 4 6 1992 563 573
4. C. Castellano, I.B. Introini-Collison, and J.L. McGaugh Interaction of beta-endorphin and GABAergic drugs in the regulation of memory storage Behav. Neural Biol. 60 2 1993 123 128
5. J.N. Crawley Cholecystokinin potentiation of dopamine-mediated behaviors in the nucleus accumbens Ann. N. Y. Acad. Sci. 448 1985 283 292
6. C. Durieux Characterization of [3H] CCK4 binding sites in mouse and rat brain Neuropeptides 12 3 1988 141 148
7. J.F. Flood, and J.E. Morley Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides Peptides 10 4 1989 809 813
8. J.F. Flood, G.E. Smith, and J.E. Morley Modulation of memory processing by cholecystokinin: dependence on the vagus nerve Science 236 4803 1987 832 834
9. K. Fuxe Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin Ann. N. Y. Acad. Sci. 668 1992 186 204
10. K. Fuxe Receptor-receptor interactions and their relevance for receptor diversity. Focus on neuropeptide/dopamine interactions Ann. N. Y. Acad. Sci. 757 1995 365 376
11. M. Gallagher Naloxone enhancement of memory processes: effects of other opiate antagonists Behav. Neural Biol. 35 4 1982 375 382
12. P. Gaudreau, G.J. Lavigne, and R. Quirion Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites Neuropeptides 16 1 1990 51 55
13. P. Gerhardt Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8S Peptides 15 4 1994 689 697
14. S.H. Gut Solubilization and characterisation of the cholecystokininB binding site from pig cerebral cortex Eur. J. Pharmacol. 172 4-5 1989 339 346
15. E.M. Hadac Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation Pancreas 13 2 1996 130 139
16. A. Harfstrand, K. Fuxe, and L.F. Agnati Evidence that intracisternal injections of cholecystokinin-8 counteracts the cardiovascular effects of intracisternally injected adrenaline and neuropeptide Y in the alpha-chloralose anaesthetized rat J. Hypertens Suppl. 4 6 1986 S251 S253
17. K.L. Holland, P. Popper, and P.E. Micevych Infusion of CCK-A receptor mRNA antisense oligodeoxynucleotides inhibits lordosis behavior Physiol. Behav. 62 1997 537 543
18. T. Honda Differential gene expression of CCK-A and CCK-B receptors in the rat brain Mol. Cell. Neurosci. 4 1993 143 154
19. M. Ito Functional characterization of human brain cholecystikinin-B receptor J. Biol. Chem. 268 1993 (Agust 25) 18300 18305
20. K. Kennedy Identification of a region of the N-terminal of the human CCKA receptor essential for the high affinity interaction with agonist CCK Biochem. Biophys. Res. Commun. 213 3 1995 845 852
21. J.L. Martinez Jr., S.B. Weinberger, and G. Schulteis Enkephalins and learning and memory: a review of evidence for a site of action outside the blood-brain barrier Behav. Neural Biol. 49 2 1988 192 221
22. P.E. Micevych, and K. Sinchak Estrogen and endogenous opioids regulate CCK in reproductive circuits Peptides 22 2001 1235 1244
23. P.E. Micevych Induction of CCK mRNA levels in the limbic-hypothalamic circuit: time course and site-specific effects of estrogen J. Neurobiol. 30 1996 465 479
24. P.E. Micevych, C.B. Eckersell, and K. Sarafzadeh Acute estrogen stimulates cholecystokinin (CCK) mRNA expression in the limbic-hypothalamic circuit of the female rat Society for Neuroscience, Washington, D.C., USA 1996
25. T. Moran Two brain cholecystokinin receptors: implications for behavioral actions Brain Res. 362 1986 175 179
26. V. Mutt, and J.E. Jorpes Structure of porcine cholecystokinin- pancreozymin: I. Cleavage with thrombin and with trypsin Eur. J. Biochem. 6 1968 156 162
27. F. Noble A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test Eur. J. Pharmacol. 273 1-2 1995 145 151
28. F. Noble International union of pharmacology: XXI. Structure, distribution, and functions of cholecystokinin receptors Pharmacol. Rev. 51 4 1999 745 781
29. S. Nomoto Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor Physiol. Behav. 66 5 1999 869 872
30. M.F. O'Neal Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task Psychoneuroendocrinology 21 1 1996 51 65
31. M.G. Packard Posttraining estrogen and memory modulation Horm. Behav. 34 2 1998 126 139
32. C.A. Paronis, and J.H. Woods Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats Eur. J. Pharmacol. 337 1 1997 27 34
33. R.V. Rao Cholecystokinin-induced desensitization, receptor phosphorylation, and internalization in the CHP212 neuroblastoma cell line J. Neurochem. 68 6 1997 2356 2362
34. S.E. Shaywitz Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks JAMA 281 13 1999 1197 1202
35. B.B. Sherwin Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women Psychoneuroendocrinology 13 4 1988 345 357
36. K. Sinchak, and P. Micevych Visualizing activation of opioid circuits by internalization of G protein-coupled receptors Mol. Neurobiol. 27 2 2003 197 222
37. H.A. Stark CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors Biochim. Biophys. Acta 1010 2 1989 145 150
38. E.M. Unterwald Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels Brain Res. Mol. Brain Res. 33 2 1995 351 355
39. T.W. Vanderah Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception NeuroReport 5 18 1994 2601 2605
40. A. van der Bent, I. van den Brink, P.A. Ijzerman, I. van Wijngaarden, and W. Soudijn Synthesis and biological evaluation of lorglumide-like hybrid cholecystokinin-A receptor antagonists Drug Dev. Res. 31 3 1994 197 205
41. J.J. Vanderhaeghen, J.C. Signeau, and W. Gepts New peptide in vertebrate CNS reacting with antigastrin antibodies Nature 257 1975 604 605
42. X. Wang, and J. Han Modification of cholecystokinin octapeptide of the binding of mu-, delta, and kappa-opioid receptors J. Neurochem. 55 4 1990 1379 1382
43. X.J. Wang Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors Life Sci. 45 2 1989 117 123
44. N.G. Weiland, and P.M. Wise Estrogen and progesterone regulate opiate receptor densities in multiple brain regions Endocrinology 126 2 1990 804 808